ArticleAsian Pacific journal of cancer prevention : APJCP2026
Characteristics of Lymph Node Metastasis in Esophageal Squamous-Cell Carcinoma Undergoing Upfront Minimally Invasive Esophagectomy: A Prospective Surgical Cohort Study.
Article in Asian Pacific journal of cancer prevention : APJCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThis study aims to evaluate the characteristics of lymph node metastasis (LNM) in patients with early esophageal squamous cell carcinoma (ESCC) undergoing upfront minimally invasive esophagectomy and extended two-field lymph node dissection. PATIENTS AND
methodsThis prospective study was conducted from October 2022 to May 2024. All patients with early esophageal squamous cell carcinoma (ESCC) who underwent minimally invasive esophagectomy and extended two-field lymph node dissection were selected for this study. Postoperative lymph nodes were divided into the upper thoracic, middle thoracic, lower thoracic, and abdominal lymph node groups. Univariate and multivariable logistic regression analyses were performed to identify risk factors associated with lymph node metastasis (LNM). Disease-free survival (DFS) was assessed using the Kaplan-Meier method.
resultsThe overall rate of LNM was 30%, with increasing incidence by pathological T stage: 14.3% in pT1a, 32.1% in pT1b, and 50% in pT2. LNM was most frequently observed in upper thoracic and abdominal lymph node groups. Univariate analysis identified poor differentiation, lymphovascular/perineural invasion (LVI/PNI), tumor size >2 cm, and increased esophageal wall thickness on endoscopic ultrasound as significant risk factors. However, in multivariable analysis, only tumor size >2 cm remained independently associated with LNM (OR 5.47; 95% CI: 1.05-32.65; p = 0.04). Patients without LNM had significantly longer DFS compared to those with LNM (22.4 vs. 14.5 months; p = 0.003).
conclusionLymph node metastasis can occur even in early-stage esophageal squamous cell carcinoma. Poor differentiation, lymphovascular/perineural invasion, tumor size >2 cm, and esophageal wall thickness on endoscopic ultrasound were identified as independent prognostic factors for lymph node metastasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.